These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16680154)

  • 1. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material.
    Kalhor N; Zander DS; Liu J
    Mod Pathol; 2006 Aug; 19(8):1117-23. PubMed ID: 16680154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
    Liu J; Farhood A
    Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
    Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
    Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
    Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
    Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach.
    Zhang H; Liu J; Cagle PT; Allen TC; Laga AC; Zander DS
    Mod Pathol; 2005 Jan; 18(1):111-8. PubMed ID: 15309021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p63 immunostaining in destained bronchoscopic cytological specimens.
    Shtilbans V; Szporn AH; Wu M; Burstein DE
    Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas.
    Sinna EA; Ezzat N; Sherif GM
    J Egypt Natl Canc Inst; 2013 Dec; 25(4):209-18. PubMed ID: 24207093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance and accuracy of p63 and TTF-1 for better approach of small cell lung carcinoma versus poorly differentiated nonkeratinizing squamous cell carcinoma.
    Gurguş D; Grigoraş ML; Motoc AGM; Zamfir CL; Cornianu M; Faur CI; Pop DL; Folescu R
    Rom J Morphol Embryol; 2019; 60(1):139-143. PubMed ID: 31263838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma.
    Liu J; Farhood A
    Acta Cytol; 2004; 48(5):635-40. PubMed ID: 15471255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D
    Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
    Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
    Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
    Sethi S; Geng L; Shidham VB; Archuletta P; Bandyophadhyay S; Feng J; Madan S; Shi D; Tranchida P; Giorgadze T
    Cytojournal; 2012; 9():10. PubMed ID: 22582081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.